scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1048474700 |
P356 | DOI | 10.1203/00006450-200201000-00017 |
P698 | PubMed publication ID | 11756646 |
P5875 | ResearchGate publication ID | 11600426 |
P2093 | author name string | Stefano Cianfarani | |
Caterina Geremia | |||
Carolyn D Scott | |||
Daniela Germani | |||
P2860 | cites work | ??? | Q57369483 |
The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease | Q33646822 | ||
Antenatal glucocorticoids and programming of the developing CNS. | Q33858306 | ||
In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells | Q34147682 | ||
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty | Q34988730 | ||
Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation? | Q35627562 | ||
Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells | Q40917043 | ||
Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport | Q40918547 | ||
Regulation of soluble insulin-like growth factor II/mannose 6-phosphate receptor in human serum: measurement by enzyme-linked immunosorbent assay | Q40972971 | ||
Weight in infancy and death from ischaemic heart disease | Q41277168 | ||
Basal ACTH, Corticosterone and Corticosterone-Binding Globulin Levels over the Diurnal Cycle, and Age-Related Changes in Hippocampal Type I and Type II Corticosteroid Receptor Binding Capacity in Young and Aged, Handled and Nonhandled Rats | Q42451471 | ||
Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid | Q42521524 | ||
Insulin-Like Growth Factor Binding Proteins in Maternal Serum Throughout Gestation and in the Puerperium: Effects of a Pregnancy-Associated Serum Protease Activity* | Q46189339 | ||
Growth in full-term small-for-gestational-age infants: from birth to final height | Q47344703 | ||
IGF-I and IGF-binding protein-1 are related to cortisol in human cord blood. | Q47979227 | ||
The cortisol-cortisone shuttle in children born with intrauterine growth retardation. | Q51561709 | ||
Can Excess Glucocorticoid, Predispose to Cardiovascular and Metabolic Disease in Middle Age? | Q52177273 | ||
Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. | Q54023387 | ||
Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth | Q58995516 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cortisol | Q190875 |
intrauterine growth restriction | Q1671598 | ||
P304 | page(s) | 94-99 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | Pediatric Research | Q7159215 |
P1476 | title | Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis? | |
P478 | volume | 51 |
Q46691222 | Association of serum lipid concentrations, insulin resistance index and catch-up growth with serum cortisol/cortisone ratio by liquid chromatography tandem mass spectrometry in children born small for gestational age. |
Q39745053 | Associations of anthropometric characteristics with blood cholesterol fractions among adults. The Greek EPIC study |
Q46255530 | Catch-up growth in body mass index is associated neither with reduced insulin sensitivity nor with altered lipid profile in children born small for gestational age. |
Q51750910 | Cortisol-cortisone ratios in small for gestational age (SGA) children without postnatal catch-up growth. |
Q38204152 | Development of food intake controls: neuroendocrine and environmental regulation of food intake during early life |
Q93197107 | Developmental responses to early-life adversity: Evolutionary and mechanistic perspectives |
Q34566070 | Dyslipidaemia and undernutrition in children from impoverished areas of Maceió, state of Alagoas, Brazil |
Q34318963 | Early alteration of structural and functional brain development in premature infants born with intrauterine growth restriction |
Q46636056 | Early deprivation and home basal cortisol levels: a study of internationally adopted children. |
Q38259690 | Early postnatal alteration of body composition in preterm and small-for-gestational-age infants: implications of catch-up fat. |
Q90542985 | Effect of Dydrogesterone on the Outcome of Idiopathic Intrauterine Growth Restriction: A Double-blind Clinical Trial Study |
Q38005245 | Effect of intrauterine growth retardation on liver and long-term metabolic risk |
Q28478640 | Effects of cord serum insulin, IGF-II, IGFBP-2, IL-6 and cortisol concentrations on human birth weight and length: pilot study |
Q90214503 | Effects of dietary methionine restriction on postnatal growth, insulin sensitivity, and glucose metabolism in intrauterine growth retardation pigs at 49 and 105 d of age |
Q46674606 | Endocrine profile of children with intrauterine growth retardation |
Q35189277 | Fetal and childhood growth patterns associated with bone mass in school-age children: the Generation R Study |
Q53919350 | Foetal origins of adult diseases: just a matter of stem cell number? |
Q37682708 | Growth and body composition in very young SGA children. |
Q41905573 | Insulin sensitivity in children born small for gestational age (SGA). |
Q51978504 | Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. |
Q39367395 | Nutritional support for low birth weight infants: insights from animal studies |
Q51499498 | Placental restriction alters circulating thyroid hormone in the young lamb postnatally. |
Q43928651 | Prenatal lipid-based nutrient supplements increase cord leptin concentration in pregnant women from rural Burkina Faso |
Q35842887 | Should recombinant human growth hormone therapy be used in short small for gestational age children? |
Search more.